Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

GVK licenses its Toxicity Database to AstraZeneca
March 2008
SHARING OPTIONS:

HYDERABAD, India—GVK Biosciences announced that it has licensed its Mechanism Based Toxicity Database (MBT) to AstraZeneca. MBT has over 13,000 drug and drug-like compounds, their routes of metabolism, toxic indications and the numerical values of the measures of toxicity. The data has been manually curated from more than 35,000 individual references. The license represents an extension of the existing license of all the GVK Target and Drug databases. The GVK Databases contain more than 3.2 million compounds manually curated from patents and journals and represent more than 7 million quantitative SAR data points.
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.